New hope for rare cholesterol disease: experimental drug enters phase 2 trial
Disease control
Recruiting now
This study tests an experimental drug called EDP167 in 20 adults with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing very high cholesterol. The drug aims to lower harmful cholesterol levels. Participants will receive multiple injections and be m…
Phase: PHASE2 • Sponsor: Eddingpharm (Zhuhai) Co., Ltd. • Aim: Disease control
Last updated May 08, 2026 12:02 UTC